Considering that substrates for P-gp include toxic endogenous substrates, xenobiotics, and many clinically important drugs, such as anticancer, antiviral, and central nervous system-related drugs, impaired P-gp efflux function at the BBB in PD is likely to elevate the levels of toxic endogenous substrates and xenobiotics. Here, PGP is linked to Parkinson disease.